| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15,986 |
13,954 |
$1.28M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,233 |
7,411 |
$704K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,889 |
5,336 |
$695K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,484 |
5,840 |
$369K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,781 |
3,344 |
$164K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,706 |
3,281 |
$138K |
| 99050 |
|
8,429 |
7,345 |
$50K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,276 |
2,104 |
$32K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
380 |
328 |
$20K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
158 |
142 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
350 |
322 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
77 |
72 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
31 |
25 |
$421.72 |
| 81002 |
|
135 |
120 |
$276.18 |
| 81025 |
|
14 |
12 |
$132.71 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
68 |
63 |
$93.84 |